SUBSCRIBE
SUBSCRIBE

Are Patent Deals Slowing Cheaper Drugs? - European Commission (EC) Reveals

January 18, 2011 | 
1 min read

(Reuters) - The EU regulator said on Monday it was pressing pharmaceutical companies for more information on their patent deals with generic companies to make sure there is no delay in cheaper drugs coming to market.

Europe
MORE ON THIS TOPIC
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Regulatory
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
March 7, 2025
 · 
2 min read
 · 
Tristan Manalac
The EMA's former headquarters in London
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Weigh scales on pink background, top view with space for text. Overweight concept
Obesity
UK Pharmacies Regulator Wants Tighter Checks on Weight Loss Injections
February 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Government
Trump’s Tariffs Threaten Big Pharma With Higher Costs and Slimmer Margins
February 3, 2025
 · 
3 min read
 · 
Tristan Manalac